Purchase Order 75N98C25P00068

Award Date 5/22/25
Potential Completion Date 5/21/26
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $150,000.00 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for a license and warranty for a PromethION 48 DNA/RNA sequencing system, with a period of performance through October 27, 2029. Oxford Nanopore Technologies has secured multiple prime contracts and...
This is a $232,150 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian federal agency, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of PROMETHION FLOW CELL PACKS, which are a key consumable component of Oxford Nanopore's PromethION sequencing platform. The contract has a period of performance through May 1, 2028. Oxford Nanopore Technologies Inc. is an established federal...
This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for $21,588.00 in equipment. The contract has no set-aside designation. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...
This federal contract award, valued at $44,838.00, was made by the National Institute on Aging (NIA), a civilian agency under the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the procurement of Promethion flow cell packs and ligation sequencing kits, which are used in Oxford Nanopore's next-generation genomic sequencing platforms. The contract is a firm fixed-price purchase order with a...
This is a $161,638 firm-fixed-price purchase order awarded by the Northeast Area division of a civilian federal agency to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of ROSEN - Oxford Nanopore FLO-PRO002 Promethion Flow Cell Packs, which are consumable supplies for Oxford Nanopore's PromethION DNA/RNA sequencing platform. The contract has a completion date of September 14, 2022 and does not have a set-aside designation....
This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $101,655.00 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for a Nanopore Technology Sequencing Instrument. The contract has no set-aside designation and was awarded on September 26, 2019, with a completion date of October 31, 2019. Oxford Nanopore Technologies Inc. is a division of Oxford Nanopore Technologies PLC,...
This is a $13,621 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of a NIDDK - Ligation Sequencing Kit and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is the prime contractor and has received multiple federal contract awards, including Indefinite Delivery...
This is a $95,435 firm-fixed-price purchase order (contract) awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the supply of NANOPORE - GRIDION, a next-generation genomic sequencing platform. There is no set-aside designation associated with this award. Oxford Nanopore Technologies Inc. has...
This firm fixed price contract was awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization. The $10,928.00 award is for the delivery of Oxford Nanopore's DNA sequencing flow cells and reagents to support long-read sequencing activities at the agency's DNA Sequencing Core. The contract has a completion date of November 7, 2023 and does not utilize any...

This is a $24,950 firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for a PROMETHION SEQUENCING INSTRUMENT AND REAGENT STARTER PACKAGE, with a performance period ending on May 21, 2026. Oxford Nanopore Technologies Inc. is the prime contractor and there are no subcontractors mentioned. The contract is not a set-aside. Oxford Nanopore Technologies Inc. has been awarded various federal contracts and blanket purchase agreements by agencies such as the Department of Defense, Department of Health and Human Services, and U.S. Department of Agriculture to provide advanced genomic sequencing platforms, reagents, and associated services to support government research initiatives in areas like infectious disease tracking, agricultural genomics, and biomedical studies.

Generated 5/24/25, 10:44 AM